SAN DIEGO--(BUSINESS WIRE)--Tandem Diabetes Care, Inc. (Nasdaq: TNDM), a leading insulin delivery and diabetes technology company, today announced it has signed a multi-year collaboration agreement ...

Tandem Diabetes Care, Inc. ( NASDAQ: TNDM) Morgan Stanley 23rd Annual Global Healthcare Conference September 10, 2025 9:15 AM EDT ...

Analysts have set 12-month price targets for Tandem Diabetes Care, revealing an average target of $19.78, a high estimate of ...

Oppenheimer analyst Suraj Kalia assumed coverage of Tandem Diabetes (TNDM) with an Outperform rating and price target of $22, down from $44. The ...

Tandem Diabetes Care, Inc. TNDM is well-poised for growth in the coming quarters, backed by its impressive lineup of new products. The flourishing diabetes market provides a favorable opportunity for ...

SAN DIEGO--(BUSINESS WIRE)--Tandem Diabetes Care, Inc. (NASDAQ: TNDM), a leading insulin delivery and diabetes technology company, today announced the United States commercial launch of its new Tandem ...

In the last three months, 4 analysts have published ratings on Tandem Diabetes Care TNDM, offering a diverse range of perspectives from bullish to bearish. The table below provides a snapshot of their ...

Tandem Diabetes Care announced plans to link its automated insulin delivery systems with an upcoming wearable monitor from Abbott that aims to measure glucose as well as ketone levels. The dual sensor ...

The prognosticator behind that piece of bad news was Citigroup's Joanne Wuensch, who issued one of her bank's 90-day catalyst watches on Tandem stock before the market open. Wuensch wrote in her ...